Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced that Kaushik J. Dave, Ph.D., President and CEO of Actinium will present a corporate overview and business update to an audience of investors, pharmaceutical executives, and strategic partners at the NewYorkBIO-CONference on Wednesday, May 14 , 2014 at 10:00 am ET at Time Warner Center, New York, New York.
Help employers find you! Check out all the jobs and post your resume.
